Stockscreener 앱 받기
43.35
2.06%
-0.91
시간 외 거래:
43.86
0.51
+1.18%
전일 마감가:
$44.26
열려 있는:
$43.57
하루 거래량:
917.88K
Relative Volume:
0.76
시가총액:
$1.25B
수익:
$915.25M
순이익/손실:
$131.14M
주가수익비율:
9.6936
EPS:
4.472
순현금흐름:
$96.71M
1주 성능:
-20.95%
1개월 성능:
-19.75%
6개월 성능:
-52.15%
1년 성능:
-71.34%
1일 변동 폭
$43.03
$45.09
1주일 범위
$43.03
$48.40
52주 변동 폭
$43.03
$161.88
Inspire Medical Systems Inc Stock (INSP) Company Profile
명칭
Inspire Medical Systems Inc
전화
763-957-5037
주소
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INSP
Inspire Medical Systems Inc
|
43.35 | 1.28B | 915.25M | 131.14M | 96.71M | 4.472 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-13 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2026-02-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2026-02-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2026-01-27 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2026-01-22 | 다운그레이드 | Truist | Buy → Hold |
| 2025-12-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-12-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-11-26 | 업그레이드 | Truist | Hold → Buy |
| 2025-11-25 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-11-24 | 업그레이드 | Stifel | Hold → Buy |
| 2025-11-04 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-10-24 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-09-22 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-09-02 | 개시 | Evercore ISI | Outperform |
| 2025-08-05 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-08-05 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-08-05 | 다운그레이드 | Truist | Buy → Hold |
| 2024-11-20 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-05-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-04-19 | 개시 | RBC Capital Mkts | Outperform |
| 2024-03-19 | 개시 | Morgan Stanley | Overweight |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2024-01-19 | 개시 | Jefferies | Buy |
| 2024-01-02 | 다운그레이드 | Stifel | Buy → Hold |
| 2023-12-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-04-14 | 개시 | Mizuho | Buy |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-12-13 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-04-13 | 개시 | Truist | Buy |
| 2022-04-06 | 개시 | Wolfe Research | Peer Perform |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-01-04 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-12-15 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-11-03 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-11-03 | 업그레이드 | Oppenheimer | Underperform → Perform |
| 2020-09-22 | 개시 | JP Morgan | Overweight |
| 2020-09-02 | 개시 | Robert W. Baird | Outperform |
| 2020-08-06 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-07-15 | 개시 | Goldman | Buy |
| 2020-06-18 | 재확인 | Piper Sandler | Overweight |
| 2020-05-18 | 개시 | Lake Street | Buy |
| 2020-04-28 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-04-09 | 개시 | Piper Sandler | Overweight |
| 2020-01-28 | 개시 | Oppenheimer | Underperform |
| 2020-01-27 | 개시 | Oppenheimer | Underperform |
| 2019-11-06 | 업그레이드 | Berenberg | Sell → Hold |
| 2019-02-05 | 개시 | Dougherty & Company | Buy |
| 2018-11-28 | 개시 | Berenberg | Sell |
| 2018-10-29 | 개시 | Leerink Partners | Outperform |
| 2018-05-29 | 개시 | Guggenheim | Buy |
| 2018-05-29 | 개시 | Stifel | Buy |
| 2018-05-29 | 개시 | Wells Fargo | Outperform |
모두보기
Inspire Medical Systems Inc 주식(INSP)의 최신 뉴스
Inspire Medical Systems director Shawn McCormick sells $31,535 stock By Investing.com - Investing.com South Africa
Inspire Medical Systems director Shawn McCormick sells $31,535 stock - Investing.com
Director at Inspire Medical (NYSE: INSP) sells 696 company shares - Stock Titan
Things Look Grim For Inspire Medical Systems, Inc. (NYSE:INSP) After Today's Downgrade - Yahoo Finance
5 Insightful Analyst Questions From Inspire Medical Systems’s Q1 Earnings Call - TradingView
Inspire Medical Systems (INSP) Is Down 18.8% After Cutting 2026 Outlook And Filing Share Offering – Has The Bull Case Changed? - Sahm
Inspire Medical Systems (INSP) Is Down 18.8% After Cutting 2026 Guidance Amid Reimbursement ChallengesWhat's Changed - Yahoo Finance
Inspire Medical Systems, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:INSP) 2026-05-08 - Seeking Alpha
[144] Inspire Medical Systems, Inc. SEC Filing - Stock Titan
INSP SEC FilingsInspire Medical 10-K, 10-Q, 8-K Forms - Stock Titan
INSP Stock Price, Quote & Chart | INSPIRE MEDICAL SYSTEMS INC (NYSE:INSP) - ChartMill
INSP Maintained by Oppenheimer -- Rating Remains at Perform - GuruFocus
Inspire Medical Systems Inc (INSP) Stock News & Articles - 24/7 Wall St.
symbol__ Stock Quote Price and Forecast - CNN
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $56 - Moomoo
Inspire Medical Systems (INSP) Q1 earnings and revenues top estimates - MSN
Inspire Medical Systems stock hits 52-week low at $45.00 By Investing.com - Investing.com Australia
Inspire Medical Systems reports loss of USD 1.1M in Q1 2026 - Medical Buyer
Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip (NYSE:INSP) - Seeking Alpha
Inspire Medical Shareholders Approve Board Declassification and Governance Changes - TipRanks
Investors back new equity plan and board changes at Inspire Medical (NYSE: INSP) - Stock Titan
Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down - Zacks Investment Research
Inspire Medical Systems (INSP) Stock Trades Down, Here Is Why - TradingView
Inspire Medical Systems Faces Limited Visibility, RBC Says - marketscreener.com
Stifel cuts Inspire Medical stock price target on weak guidance By Investing.com - Investing.com Canada
Inspire Medical Systems Q1 2026 earnings preview - MSN
Piper Sandler Downgrades Inspire Medical Systems to Neutral From Overweight, $85 Price Target - Moomoo
Inspire Medical Systems Is Maintained at Hold by Truist Securities - Moomoo
Inspire Medical Systems stock hits 52-week low at $45.00 - Investing.com
Inspire Medical Systems Sees 2026 EPS 7c-EPS 62c >INSP - Moomoo
Inspire Medical Systems Sees 2026 Adj EPS 75c-Adj EPS $1.25 >INSP - Moomoo
Inspire Medical Systems, Inc. Reports Q1 2026 Financial Results and Forward-Looking Statements - Minichart
RBC Cuts Price Target on Inspire Medical Systems to $45 From $56, Keeps Sector Perform Rating - marketscreener.com
Stock Market Today: Dow, S&P 500, Nasdaq Futures Rise As Traders Monitor US-Iran Ceasefire— Duolingo, Pinterest, AMD In Focus (UPDATED) - Benzinga
Truist Securities Adjusts Price Target on Inspire Medical Systems to $50 From $64, Maintains Hold Rating - marketscreener.com
Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2026 Earnings Call Transcript - Insider Monkey
BofA cuts Inspire Medical stock rating on reimbursement concerns By Investing.com - Investing.com Canada
Mizuho cuts Inspire Medical Systems stock price target on guidance reduction - Investing.com Canada
Inspire Medical Systems 1Q Adj EPS 10c >INSP - Moomoo
Assessing Inspire Medical Systems (INSP) Valuation After Prolonged Share Price Weakness - Sahm
Inspire forecasts $825M-$875M 2026 revenue amid coding and WISeR disruption - MSN
INSP Q1 Deep Dive: Coding Headwinds and WISER Program Drive Down Full-Year Outlook - TradingView
Inspire Medical Q1 2026 slides: strong earnings beat masks growth slowdown - Investing.com Canada
Inspire Medical Systems Earnings Preview: Revenue Expected Flat - IndexBox
Inspire Medical Systems, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
INSP: 2026 revenue guidance cut to $825–$875M due to reimbursement and WISeR headwinds - TradingView
Earnings call transcript: Inspire Medical beats Q1 2026 EPS forecasts By Investing.com - Investing.com South Africa
Inspire (INSP) Q1 2026 Earnings Call Transcript - The Globe and Mail
Director at Inspire Medical (INSP) granted 3,562 RSUs - Stock Titan
Inspire Medical Systems (INSP) grants 3,562 RSUs to board director - Stock Titan
Inspire Medical (INSP) director receives 3,562-share RSU award - Stock Titan
Inspire Medical Systems Inc (INSP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.34%
자본화:
|
볼륨(24시간):